BindingDB logo
myBDB logout

null

SMILES: C[C@@]1(O)CC[C@@H](Nc2c(cnn3cc(NS(=O)(=O)c4ccc(Cl)cc4)cc23)C(N)=O)C1(C)C

InChI Key: InChIKey=XWMFFRNMXBNADT-XMSQKQJNSA-N

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 141451   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Tyrosine-protein kinase JAK1


(Homo sapiens (Human))
BDBM141451
PNG
(US8921368, 23)
Show SMILES C[C@@]1(O)CC[C@@H](Nc2c(cnn3cc(NS(=O)(=O)c4ccc(Cl)cc4)cc23)C(N)=O)C1(C)C |r|
Show InChI InChI=1S/C22H26ClN5O4S/c1-21(2)18(8-9-22(21,3)30)26-19-16(20(24)29)11-25-28-12-14(10-17(19)28)27-33(31,32)15-6-4-13(23)5-7-15/h4-7,10-12,18,26-27,30H,8-9H2,1-3H3,(H2,24,29)/t18-,22-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

US Patent
n/an/a 259n/an/an/an/a7.425



Bristol-Myers Squibb Company

US Patent


Assay Description
The assay reactions were performed in U-bottom 384-well plates. The final assay volume was 30 ul prepared from 15 ul additions of enzyme and substr...


US Patent US8921368 (2014)


BindingDB Entry DOI: 10.7270/Q2HH6HS7
More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK3


(Homo sapiens (Human))
BDBM141451
PNG
(US8921368, 23)
Show SMILES C[C@@]1(O)CC[C@@H](Nc2c(cnn3cc(NS(=O)(=O)c4ccc(Cl)cc4)cc23)C(N)=O)C1(C)C |r|
Show InChI InChI=1S/C22H26ClN5O4S/c1-21(2)18(8-9-22(21,3)30)26-19-16(20(24)29)11-25-28-12-14(10-17(19)28)27-33(31,32)15-6-4-13(23)5-7-15/h4-7,10-12,18,26-27,30H,8-9H2,1-3H3,(H2,24,29)/t18-,22-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

US Patent
n/an/a 23.4n/an/an/an/a8.025



Bristol-Myers Squibb Company

US Patent


Assay Description
Kinase reactions consisted of 5 ng of JAK3 enzyme, 30 uM CSKtide substrate, 0.2 uCi gamma-33P ATP, 8 uM ATP in 30 ul kinase buffer (50 mM Hepes, pH ...


US Patent US8921368 (2014)


BindingDB Entry DOI: 10.7270/Q2HH6HS7
More data for this
Ligand-Target Pair